TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Safety and Tolerability of Volixibat
Endpoint domain: Adverse events/effects
Primary endpoint: Number of General Practitioner (GP) Appointments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Referrals to Psychiatrist
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total Healthcare Costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of patients developing 1 stage improvement in Acute kidney injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Quality of Life Perception Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Compliance with management recommendations
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Wound Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beck Depression Screening Scale for Primary Care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Interpersonal relationships emotion regulation scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Multidimensional Perceived Social Support Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cognitive functioning using a computerized battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Severity of posttraumatic stress disorder (PTSD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical health rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: motor pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vocal range profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with Blood stream infection (BSI)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with Severe blood culture negative infection
Endpoint domain: Adverse events/effects
Primary endpoint: Embryo re-biopsy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Embryo transfer rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in weighted modified Rankin scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alanine transaminase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Aspartate transferase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Longterm Survival
Endpoint domain: Mortality/survival
Primary endpoint: Changes in muscle strength in the lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage change in pressure ulcer length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage change in pressure ulcer depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage change in pressure ulcer area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage change in proportion of viable wound tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Forced expiratory flow in 1 second
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Peak expiratory flow (PEFR [pp])
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of pregnancies leading to live birth
Endpoint domain: Mortality/survival
Primary endpoint: Objective refractive error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in MDS-UPDRS Part III Subscore
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Change from Baseline EB-45 Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Surgical stress response (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-oral geometric changes of the alveolar ridge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thermographic changes of the alveolar ridge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental confidence in managing food allergy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rates of suboptimal blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number and Percentage of Participants With Symptomatic Influenza Virus Infection After Challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Peak Viral Load (VL) After Challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Duration of Viral Shedding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognostic Nutritional Index (PNI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer Assessment (FMA) scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30m-sprint Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Striatal response to frustrative nonreward (FNR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-related change in striatum-habenula functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-related change in striatal response to FNR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor Function Measure scale (MFM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of Upper Limb (PUL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative fentanyl consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Suicide Crisis Syndrome-Checklist (SCS-C)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Altered states of consciousness profile (5D-ASC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subjective effect ratings over time
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in the Annualized Relapse Rate at Week 50
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to First Adjudicated On-trial Relapse through Week 50
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who achieved BICLA response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TMS evoked potential amplitude change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: functional magnetic resonance images brain functional connection change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: diffusion tensor imaging fiber connectivity change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in progression of motor symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Agreement in establishing surveillance intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of radiation-induced otitis media
Endpoint domain: Adverse events/effects
Primary endpoint: Change in insulin dosage (basal and bolus)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: brain fMRI-based activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline horizontal width of ridge at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline vertical height of ridge at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of IgG and IgM antibodies to SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Loss of IgG and IgM antibodies to SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Electromyographic activity of gluteus medius muscle during step-down test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Electromyographic activity of quadriceps muscle during step-down test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Electromyographic activity of hamstring muscles during step-down test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cardiometabolic risk profile (DIAL risk score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Delirium event and severity
Endpoint domain: Adverse events/effects
Primary endpoint: Change in foot-ankle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in running economy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Running-related injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Suppression of melatonin production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Phase shift in the timing of melatonin onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Hospitalization for cardiac causes
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Pain associated with dressing changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biodex Balance System
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ProQOL Health Care Workers version
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CD-RISC10
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Human Papillomavirus (HPV) virus integration test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Human Papillomavirus (HPV) genotyping tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: weight of consumed ingesta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of relapse/progression-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Inter-rater reliability of the Functional Assessment for Burns (FAB) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: regional tissue saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erectile Function Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutrophil-lymphocyte ratio (NLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Platelet-lymphocyte ratio (PLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in esophageal alpha1 anti-trypsin (A1AT) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent fall requiring ED revisit at 6 months
Endpoint domain: Adverse events/effects
Primary endpoint: Fall-related injury at 6 months
Endpoint domain: Adverse events/effects
Primary endpoint: Change in CIDP Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum postoperative pain score at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procalcitonin (PCT) measurements in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histological resolution of NASH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Incidence of Device and procedure related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Bi-Ventricular capture on 12 lead EKG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of a composite of treatment-related serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Knee Injury Osteoarthritis Outcome Score (KOOS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Veterans Rand 12 Item Health Survey (VR-12)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Finger pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of thrombocytopenia and/or leukopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of Decreased Oxygen Saturation
Endpoint domain: Adverse events/effects
Primary endpoint: Interruption Rate of Bronchoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in gene expression from control arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in gene expression between blood samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1 year progression-free survival (PFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Severity of symptoms in individuals with IBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of IMMUNA treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of Dose Limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Negative effects from using the app
Endpoint domain: Adverse events/effects
Primary endpoint: change in gonadotropin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean Change in ABC-I Subscale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Participants Persisting to Treatment With Vedolizumab IV
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pain in Visual Analogue Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Function in Patient Rated Wrist Evaluation Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Range Of Motion in Flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction Level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Vulvar Quality of Life Index 11 (VQLI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Currently using PPFP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postnatal Care uptake
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Timing of Postnatal Care (PNC)
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Frequency of occurrence of SSc at 5 years
Endpoint domain: Mortality/survival
Primary endpoint: Area Under the Concentration versus Time Curve from 0 to Infinity (AUC0-inf) of enlicitide in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent terminal half-life (t1/2) of enlicitide in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal residual disease negative complete remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insomnia Severity Index change
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Maximum tolerated dose for cryodevitalization cycle duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion Rate of 16 Prespecified Views
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of people with complete remission of migraine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Pharmacokinetic- AUC 0-t
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Pharmacokinetic- AUC 0-∞
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Pharmacokinetic- Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sub-clinical levels of low wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: NRS (Numerical Rating Scale) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional movement screen score (FMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood surfactant protein-D (SP-D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Image Contrast Resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Image Uniformity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Qualitative Image Comparison
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset time and duration of sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Onset time and duration of motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Muscle Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peripheral Muscle Strength- Isotonic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral Muscle Strength-Isometric
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Failure Somatic Perception Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total MACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Transit-times of gastrointestinal tract
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Erosion size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine-specific disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Healthcare Resource Utilization (HCRU)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Carbon Monoxide (CO) Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants experiencing any immediate reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants reporting any solicited local Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants reporting any solicited systemic Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants experiencing any unsolicited Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with any Medically Attended Adverse Event (MAAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants experiencing any Adverse Event of Special Interest (AESI)
Endpoint domain: Adverse events/effects
Primary endpoint: AIM2 inflammasome in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: NFL and sTREM2 in cerebrospinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Patient perceived experiences of living with asthma
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FeNO concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of investigator-confirmed HAE attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bloody stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: necrotizing entercolitis (NEC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Antibody binding activity in plasma samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neutralizing activity of plasma samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bone loss in the horizontal direction (BL-H)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of hernia recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of CTCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients willing to consent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients willing to participate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent of patients who stated that the intervention was acceptable
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nutritional status of pregnant mothers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Food security level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pharmacists' Knowledge and Confidence in PrEP prescribing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: annotation accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes